Otsuka Pharmaceutical Factory has signed an agreement to acquire 20% of outstanding shares in Otsuka Pharmaceutical India Private (OPI).

The shares are currently held by Claris Lifesciences, a pharmaceutical company based in India.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

"German biopharmaceutical company Sygnis has agreed to acquire UK-based Innova Biosciences."

Based in Japan, the acquirer company manufactures and distributes industrial and pharmaceutical chemicals.

The purchase consideration for the acquisition is $20m.

German biopharmaceutical company Sygnis has agreed to acquire UK-based Innova Biosciences.

The purchase consideration for the acquisition will include €8m ($8.79m) in cash and up to 3.5 million in shares.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact